Understanding the true burden of COPD: the epidemiological challenges.
作者信息
Salvi Sundeep S, Manap Roslina, Beasley Richard
出版信息
Prim Care Respir J. 2012 Sep;21(3):249-51. doi: 10.4104/pcrj.2012.00082.
Abstract
摘要
相似文献
1
Understanding the true burden of COPD: the epidemiological challenges.
Prim Care Respir J. 2012 Sep;21(3):249-51. doi: 10.4104/pcrj.2012.00082.
2
Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease.
J Health Serv Res Policy. 2015 Oct;20(4):246-53. doi: 10.1177/1355819615579232. Epub 2015 Apr 2.
3
Chronic obstructive pulmonary disease and its comorbidities.
Panminerva Med. 2009 Jun;51(2):115-23.
4
Sleep in Chronic Obstructive Pulmonary Disease: Evidence Gaps and Challenges.
Can Respir J. 2016;2016:7947198. doi: 10.1155/2016/7947198. Epub 2016 Jun 8.
5
The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016.
Lancet Glob Health. 2018 Dec;6(12):e1363-e1374. doi: 10.1016/S2214-109X(18)30409-1. Epub 2018 Sep 12.
6
Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly.
Eur Respir J Suppl. 2003 May;40:3s-9s. doi: 10.1183/09031936.03.00403103.
7
An Epidemiological Overview of Chronic Obstructive Pulmonary Disease: What Can Real-Life Data Tell Us about Disease Management?
COPD. 2017 Mar 15;14(sup1):S3-S7. doi: 10.1080/15412555.2017.1286165.
8
Epidemiology of Chronic Obstructive Pulmonary Disease.
Clin Chest Med. 2020 Sep;41(3):315-327. doi: 10.1016/j.ccm.2020.05.002.
9
[Chronic obstructive pulmonary disease as a risk factor for coronary heart disease].
Pol Merkur Lekarski. 2015 Jan;38(223):39-41.
10
Global Chronic obstructive pulmonary disease burden attributable to air pollution from 1990 to 2019.
Int J Biometeorol. 2023 Oct;67(10):1543-1553. doi: 10.1007/s00484-023-02504-5. Epub 2023 Jul 31.
引用本文的文献
1
Factors Associated with Chronic Obstructive Pulmonary Disease: A Hospital-Based Case-Control Study.
Int J Chron Obstruct Pulmon Dis. 2023 Nov 10;18:2521-2529. doi: 10.2147/COPD.S426928. eCollection 2023.
2
Most patients with COPD are unaware of their health threats and are not diagnosed: a national-level study using pulmonary function test.
Sci Rep. 2023 Apr 11;13(1):5893. doi: 10.1038/s41598-023-32485-9.
3
Prevalence and health status of COPD in rural West Bengal.
Lung India. 2022 May-Jun;39(3):242-246. doi: 10.4103/lungindia.lungindia_439_21.
4
Systematic Review of Physical Activity, Sedentary Behaviour and Sleep Among Adults Living with Chronic Respiratory Disease in Low- and Middle-Income Countries.
Int J Chron Obstruct Pulmon Dis. 2022 Apr 18;17:821-854. doi: 10.2147/COPD.S345034. eCollection 2022.
5
Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke.
Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211039769. doi: 10.1177/17534666211039769.
6
Prevalence of chronic obstructive pulmonary disease in India: A systematic review and meta-analysis.
Lung India. 2021 Nov-Dec;38(6):506-513. doi: 10.4103/lungindia.lungindia_159_21.
7
What is the true burden of chronic obstructive pulmonary disease in India and what are its implications at a national level?
Lung India. 2021 Nov-Dec;38(6):503-505. doi: 10.4103/lungindia.lungindia_579_21.
8
Predictors for detecting chronic respiratory diseases in community surveys: A pilot cross-sectional survey in four South and South East Asian low- and middle-income countries.
J Glob Health. 2021 Oct 30;11:04065. doi: 10.7189/jogh.11.04065. eCollection 2021.
9
Prevalence of COPD among population above 30 years in India: A systematic review and meta-analysis.
J Glob Health. 2021 Aug 21;11:04038. doi: 10.7189/jogh.11.04038. eCollection 2021.
10
Development of an educational intervention to reduce the burden of adult chronic lung disease in rural India: Inputs from a qualitative study.
PLoS One. 2021 Jul 15;16(7):e0254534. doi: 10.1371/journal.pone.0254534. eCollection 2021.
本文引用的文献
1
India needs a national COPD prevention and control programme.
J Assoc Physicians India. 2012 Feb;60 Suppl:5-7.
2
Prevalence of COPD in India: a systematic review.
Prim Care Respir J. 2012 Sep;21(3):313-21. doi: 10.4104/pcrj.2012.00055.
3
The use of the lower limit of normal as a criterion for COPD excludes patients with increased morbidity and high consumption of health-care resources.
Arch Bronconeumol. 2012 Jul;48(7):223-8. doi: 10.1016/j.arbres.2012.02.007. Epub 2012 Apr 4.
4
Recommendations for epidemiological studies on COPD.
Eur Respir J. 2011 Dec;38(6):1261-77. doi: 10.1183/09031936.00193809.
5
I have taken my umbrella, so of course it does not rain.
Thorax. 2012 Jan;67(1):88-9. doi: 10.1136/thoraxjnl-2011-200758. Epub 2011 Aug 25.
6
Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
Respir Med. 2011 Jun;105(6):907-15. doi: 10.1016/j.rmed.2011.01.008. Epub 2011 Feb 5.
7
Is exposure to biomass smoke the biggest risk factor for COPD globally?
Chest. 2010 Jul;138(1):3-6. doi: 10.1378/chest.10-0645.
8
Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance.
BMJ. 2010 Jun 25;340:c3134. doi: 10.1136/bmj.c3134.
9
Time to define the disorders of the syndrome of COPD.
Lancet. 2009 Aug 29;374(9691):670-2. doi: 10.1016/S0140-6736(09)61541-5.
10
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care.
Can Respir J. 2008 Jan-Feb;15 Suppl A(Suppl A):1A-8A. doi: 10.1155/2008/641965.
Zotero 插件